BeiGene rebrands as BeOne Medicines and redomiciles to Switzerland. Its Hopewell flagship continues driving innovation in ...

BeiGene (NASDAQ:ONC), Ltd. has officially completed its relocation from the Cayman Islands to Switzerland, now known as BeOne Medicines Ltd. This strategic move, effective May 27, 2025 ...

Sino-American biotech BeiGene has now effected its previously announced transition, becoming BeOne Medicines (Nasdaq: ONC; ...

BeOne Medicines Ltd. (NASDAQ: ONC), a global oncology company formerly known as BeiGene, Ltd., today announced its new name and redomiciliation to Switzerland are officially in effect, marking a ...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company formerly known as BeiGene, Ltd., today announced its new name and ...

a proposed name change to BeOne Medicines and its move to redomicile to Switzerland. BeiGene expects it will break even under GAAP measurements and generate positive cash flow from its operations ...

BeiGene is a BUY due to Tevimbra's approval ... Also, the company is re-domiciling from the Cayman Islands to Switzerland. Historically, the company has run operating losses its entire history ...

SAN CARLOS, Calif., May 07, 2025--BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines, Ltd., today announced financial ...

BeiGene (NASDAQ:ONC), Ltd. has officially completed its relocation from the Cayman Islands to Switzerland, now known as BeOne Medicines Ltd. This strategic move, effective May 27, 2025, was executed ...

BeiGene Ltd ( ($HK:6160) ) has provided an announcement. BeOne Medicines Ltd., a Switzerland-based company, has announced a post-effective ...